Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman Investment company hopes to create technology accelerator to speed bringing new innovations to market March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to Hellman & Friedman (H&F) for approximately $1 billion. Hellman & Friedman is a global private equity firm with investments in high-quality growth businesses. It is partnering in the transaction with Ajax Health and Zeus Health to build the Cordis business. Ajax identifies and supports scaling up disruptive technologies in the healthcare space. Zeus Health is a platform focused on investing in and operating a portfolio of emerging medical technology companies.